×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Cell: Glial Cells
cell
614 words
KG: GLIAL CELLS
2026-03-24
kind:cell-type
section:cell-types
state:published
Contents
Glial Cells
🧫
Cell Type Info
Cell Type
GLIAL CELLS
Associated Diseases
Neuronal Damage
,
Premature Senescence
,
Parkinson's Disease
,
PARKINSON'S DISEASE
,
Alzheimer's Disease
,
Parkinson'S Disease
Knowledge Graph
Related Hypotheses (30)
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Multi-Modal Stress Response Harmonization
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Heterogeneous astrocyte activation states differentially imp
Score: 0.52
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Noradrenergic-Tau Propagation Blockade
Score: 0.51
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
OPC differentiation blockade contributes to white matter deg
Score: 0.50
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
RNA Granule Nucleation Site Modulation
Score: 0.48
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Microbiota-Microglia Axis Modulation
Score: 0.48
Ocular Immune Privilege Extension
Score: 0.47
Oligodendrocyte DNA Repair Enhancement Therapy
Score: 0.46
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo
Score: 0.45
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.45
Lysosomal Membrane Repair Enhancement
Score: 0.45
Show 25 more
Related Analyses (25)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Show 20 more
Related Experiments (17)
Ex vivo IGF-I treatment in rd10 organotypic retinal explants
validation · proposed · Score: 0.90
Microglial depletion study using clodronate liposomes
exploratory · proposed · Score: 0.85
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
Proposed experiment from debate on Senolytics targeting p16/
falsification · proposed · Score: 0.40
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40
Gap Junction Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 12 more
Knowledge Graph (1 edges)
GLIAL CELLS
releases
INFLAMMATORY AND NEUROTOXIC MOLECULES